As of 2026-09-16, the Fair Value of Avidity Biosciences Inc (RNA) is -19.33 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.09 USD, the upside of Avidity Biosciences Inc is -291.54%.
With the market price of 10.09 USD and our fair value calculation, Avidity Biosciences Inc (RNA) is not a good investment. Investing in Avidity stocks now will result in a potential loss of 291.54%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2023-12-31 | 2024-12-31 | 2025-12-31 | - | - | 5Y Avg | |
| Net income | -25.12 | -49.50 | - | - | -37.31 | |
| YoY growth | -293.45% | -97.04% | - | - | -195.25% | |
| Market Cap (mil) | 215.84 |
| P/E | |
| Forward P/E |
| EPS | -3.87 |
| Avg earnings growth rate | -195.25% |
| TTM earnings | -66.13 |